Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Innovation Pharmaceuticals IPIX
(Total Views: 610)
Posted On: 02/22/2022 1:43:47 PM
Post# of 72446
Posted By: djs7
Praying and hoping there is a pursuit to a
1) mild to moderate for hospitalized covid and
2) mild to moderate for non-hospitalized covid
This would be less risky IMO and hopefully better outcome.

None of us still yet know if Remdesivir was only used with Brilacidin in the 2 USA clinical sites. If so, out of 120 patient trial with 11 trial sites, can't be more than
Quote:
20

Bril/Rem combo patients of which how many got that 5 day dose combo??? 14-16 and how many were moderate disease out of those???














(1)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site